BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cholongitas E, Pipili C, Papatheodoridis GV. Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation. World J Hepatol 2017; 9(4): 180-190 [PMID: 28217256 DOI: 10.4254/wjh.v9.i4.180]
URL: https://www.wjgnet.com/1007-9327/full/v9/i4/180.htm
Number Citing Articles
1
Hosnieh Fathi, Andrew Clark, Nathan R. Hill, Geoffrey Dusheiko. Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic reviewBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2820-z
2
Matt Driedger, Chrissi Galanakis, Curtis Cooper. Direct acting antiviral HCV treatment does not influence renal functionMedicine 2020; 99(22): e20436 doi: 10.1097/MD.0000000000020436
3
Geoffrey Dusheiko. Sherlock's Diseases of the Liver and Biliary System2018; : 436 doi: 10.1002/9781119237662.ch23
4
Evangelos Cholongitas, George V. Papatheodoridis. Hepatitis C: Care and Treatment2021; : 175 doi: 10.1007/978-3-030-67762-6_12
5
Fardad Ejtehadi, Paymun Farahvashi, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Ladan Aminlari, Nasrin Motazedian, Kourosh Kazemi, Hamed Nikoupour, Saman Nikeghbalian, Hesameddin Eghlimi, Alireza Taghavi, Mohammadreza Fattahi, Kamran Bagheri Lankarani, Seyyed Ali Malek-Hosseini. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in IranHepatitis Monthly 2021; 21(3) doi: 10.5812/hepatmon.108405
6
Experimental and Clinical Transplantation 2017; 15(6) doi: 10.6002/ect.2017.0104
7
Jong Eun Yeon. Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASLClinical and Molecular Hepatology 2018; 24(3): 278 doi: 10.3350/cmh.2018.1002
8
Larissa Sgaria Pacheco, Pedro Enrico Ventura, Roger Kist, Valter Duro Garcia, Gisele Meinerz, Cristiane Valle Tovo, Guido Pio Cracco Cantisani, Maria Lucia Zanotelli, Marcos Mucenic, Elizete Keitel. Real-world effectiveness and safety of direct-acting antivirals for the treatment of hepatitis C virus in kidney and liver transplant recipients: experience of a large transplant center in BrazilRevista do Instituto de Medicina Tropical de São Paulo 2023; 65 doi: 10.1590/s1678-9946202365059
9
Jesús Quintero, Javier Juampérez, Ecaterina Julio, Vanessa Cabello, Maria Mercadal-Hally, Pere Soler-Palacín, Óscar Segarra, Carlos Rodrigo. Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis CAnales de Pediatría 2019; 90(3): 141 doi: 10.1016/j.anpedi.2018.07.007
10
Hossein Poustchi, Sara Majd Jabbari, Shahin Merat, Amir‐Houshang Sharifi, Ali Akbar Shayesteh, Elahe Shayesteh, Mohammad Minakari, Mohammad Reza Fattahi, Maryam Moini, Fatemeh Roozbeh, Fariborz Mansour‐Ghanaei, Behrooz Afshar, Marjan Mokhtare, Taghi Amiriani, Masoomeh Sofian, Mohammad‐Hossein Somi, Shahram Agah, Iradj Maleki, Maryam Latifnia, Mojtaba Fattahi Abdizadeh, Ahmad Hormati, Masoud Khoshnia, Masoudreza Sohrabi, Zeinab Malekzadeh, Dorsa Merat, Reza Malekzadeh. The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairmentJournal of Gastroenterology and Hepatology 2020; 35(9): 1590 doi: 10.1111/jgh.14994
11
A. Oruc, A. Ersoy. Transplantation Opportunities of Hepatitis C Virus–Seropositive Patients on the Kidney Waiting ListTransplantation Proceedings 2018; 50(10): 3181 doi: 10.1016/j.transproceed.2018.04.044
12
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis CClinical and Molecular Hepatology 2018; 24(3): 169 doi: 10.3350/cmh.2018.1004
13
Jesús Quintero, Javier Juampérez, Ecaterina Julio, Vanessa Cabello, Maria Mercadal-Hally, Pere Soler-Palacín, Óscar Segarra, Carlos Rodrigo. Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescentsAnales de Pediatría (English Edition) 2019; 90(3): 141 doi: 10.1016/j.anpede.2018.07.004
14
Emine Parlak. Management of hepatitis C patients with kidney failureOrtadoğu Tıp Dergisi 2019; 11(4): 577 doi: 10.21601/ortadogutipdergisi.479176